Skip to Content

Hisamitsu Pharmaceutical Co Inc HTSUF

Morningstar Rating
$24.56 −0.66 (2.62%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HTSUF is trading at a 766% premium.
Price
$24.71
Fair Value
$37.17
Uncertainty
High
1-Star Price
$12.44
5-Star Price
$65.36
Economic Moat
Syfnff
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HTSUF is a good fit for your portfolio.

Trading Information

Previous Close Price
$25.22
Day Range
$23.7024.56
52-Week Range
$23.7036.00
Bid/Ask
$22.61 / $28.34
Market Cap
$1.86 Bil
Volume/Avg
1,351 / 789

Key Statistics

Price/Earnings (Normalized)
20.17
Price/Sales
1.90
Dividend Yield (Trailing)
2.26%
Dividend Yield (Forward)
2.21%
Total Yield
5.97%

Company Profile

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
3,682

Comparables

Valuation

Metric
HTSUF
4581
600380
Price/Earnings (Normalized)
20.1727.8314.33
Price/Book Value
1.070.841.40
Price/Sales
1.902.171.23
Price/Cash Flow
13.9414.484.33
Price/Earnings
HTSUF
4581
600380

Financial Strength

Metric
HTSUF
4581
600380
Quick Ratio
2.974.202.03
Current Ratio
3.505.162.38
Interest Coverage
799.5068.7521.41
Quick Ratio
HTSUF
4581
600380

Profitability

Metric
HTSUF
4581
600380
Return on Assets (Normalized)
5.85%2.57%3.74%
Return on Equity (Normalized)
7.33%3.09%9.97%
Return on Invested Capital (Normalized)
6.13%2.64%3.77%
Return on Assets
HTSUF
4581
600380
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
FvtcpsntpTjff$83.5 Bil
Merck KGaA ADR
MKKGY
ZfpwcwgryRcldgl$73.0 Bil
Haleon PLC ADR
HLN
SgykfwtvNdbpw$39.3 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
YjjcxlttMzs$19.6 Bil
Viatris Inc
VTRS
KhzfgytlDwxfl$13.5 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
KgqjbhvDcbs$13.2 Bil
Catalent Inc
CTLT
RvkgzxxhZnhztg$10.5 Bil
Perrigo Co PLC
PRGO
HkfzlqymvClk$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
PvwkjmcgfTyzzyf$3.6 Bil
Curaleaf Holdings Inc
CURLF
LhvgkjyPfmzz$3.2 Bil

Sponsor Center